News & Views

Adobestock 427889993

Iksuda deepens clinical pipeline

Iksuda Therapeutics deepens clinical pipeline through licensing agreement for Her2 antibody drug conjugate programme from LegoChem Biosciences

Sign up for more news

Thank you
*required field
*required field
*required field
I confirm that I have read the data protection and Privacy Policy and that I agree to the processing of my personal data